Parkinsonian DisordersInorganic ChemicalsSupranuclear Palsy, ProgressiveMultiple System AtrophyDopamineParkinson DiseaseReceptors, Dopamine D2Receptors, Dopamine D1Dopamine AgonistsReceptors, DopamineDopamine AntagonistsLevodopaBrain ChemistryReceptors, Dopamine D3Dopamine AgentsParkinson Disease, SecondaryDopamine Plasma Membrane Transport ProteinsBrain InjuriesAntiparkinson AgentsBrain NeoplasmsCorpus Striatum1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineBrainBrain MappingGlobus PallidusHypokinesiaSubstantia NigraOxidopamineMuscle RigidityNeuronsDyskinesia, Drug-InducedSubthalamic NucleusReceptors, Dopamine D5Dopamine Uptake InhibitorsBipolar DisorderDeep Brain StimulationMagnetic Resonance ImagingCarbidopaBasal GangliaApomorphineDopamine beta-HydroxylaseDyskinesiasRats, Sprague-DawleyTyrosine 3-MonooxygenaseDopaminergic NeuronsNeostriatumTremorBehavior, AnimalBrain EdemaBrain StemExtrapyramidal TractsPutamenMental DisordersBrain IschemiaMesencephalonDisease Models, AnimalDihydroxyphenylalanineMood DisordersAnxiety DisordersMovement DisordersMazindolBenserazideNeural PathwaysCerebral CortexOlivopontocerebellar AtrophiesQuinpiroleCaudate NucleusBenzazepinesNerve Tissue ProteinsAmphetamineHaloperidolTime FactorsBrain AbscessAnalysis of VarianceRacloprideMicrodialysisMotor ActivityHomovanillic AcidDiagnostic and Statistical Manual of Mental DisordersMedial Forebrain BundleNucleus Accumbens